In conclusion, our transcriptome profiling of primary tumors from our somatic model of breast cancer suggests Nr5a2 is a key mediator involved in mutant p53-driven transcriptional rewiring in breast cancers. The gene discussed is NR5A2; the disease is breast cancer.